Integrated BioPharma, Inc. (OTCMKTS:INBP) Sees Significant Decrease in Short Interest

Integrated BioPharma, Inc. (OTCMKTS:INBP) saw a large decline in short interest in the month of February. As of February 28th, there was short interest totalling 300 shares, a decline of 25.0% from the February 13th total of 400 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 32,600 shares, the days-to-cover ratio is currently 0.0 days.

Integrated BioPharma Stock Up 3.3 %

INBP stock opened at $0.32 on Friday. Integrated BioPharma has a 52 week low of $0.16 and a 52 week high of $0.42. The company has a market cap of $9.60 million, a price-to-earnings ratio of 10.57 and a beta of 0.89. The business has a fifty day simple moving average of $0.34 and a 200-day simple moving average of $0.30.

About Integrated BioPharma

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.